Reportable Laboratory Results for Meaningful Use
Laboratory Results for Reportable Diseases Message Submissions for Meaningful Use
Meaningful Use Laboratory Results for Reportable Diseases Message Submissions
The OSDH Acute Disease Service is receiving submissions of laboratory results for reportable diseases using the latest HL7 v2.5.1 ORU^R01 messaging specification (HL7 Version 2.5.1 Implementation Guide: Electronic Laboratory Reporting to Public Health, Release 1 (US Realm) (electronic version in PDF) with errata) which is available at no cost at the following link: https://www.hl7.org/implement/standards/product_brief.cfm?product_id=98.
The U.S. National Library of Medicine NLM Tools for EHR Certification and Meaningful Use web page provides free access to the SNOMED CT and LOINC vocabulary standards at the following link: http://www.nlm.nih.gov/healthit/meaningful_use.html.
Laboratory results indicating certain communicable diseases and pathogens are required to be reported to the OSDH. Please visit the OSDH What to Report site for specific details on the list of diseases and pathogens that are reportable in the State of Oklahoma.
OSDH has developed a new registration website for Public Health Meaningful Use measures and objectives.
Process for Submitting Test Messages to OSDH
1. To begin the process of submitting reportable laboratory messages, please review tutorial on how to register and then submit registration using the link* provided below.
* If you have previously submitted a registration to OSDH using the old registration form, please email MeaningfulUse@health.ok.gov ELROnboarding@health.ok.gov to obtain login information. Please include the name of the facility registering, facility address, facility phone number and contact person listed on the previous registration. You will receive a response within two business days from an OSDH Meaningful Use team member with further instruction..
2. Once the registration form is received and processed, your registration will be placed in the queue with other registrations. You will be contacted by an OSDH representative to schedule the kickoff meeting. The kickoff meeting will be held via teleconference and you are required to include your vendor in the teleconference. Failing to include your vendor will require placing your registration back into the queue and the kickoff meeting will be rescheduled at a later date.
3. Communication during the testing period is conducted via email with occasional phone calls.
Communication during the testing period is conducted via email with occasional phone calls. If you have any additional questions, please refer to the FAQs or send an email to OSDH Meaningful Use OSDH Meaningful Use.
Stage 2 alert: If you are participating in Stage 2, you are required to respond to any communication from the public health agency within 30 days. Failure to respond within two 30 day periods will result in failure of Stage 2 requirements.
Stage 1 vs. Stage 2
The following table contains laboratory results for reportable diseases requirements for stages 1 and 2. Laboratory reporting is not a requirement for Eligible Professionals.
|Eligible Hospitals (EHs) and Critical Access Hospitals (CAHs)|
|Menu Objectives||Stage 1 Meaningful Use Measures||Stage 2 Meaningful Use Measures|
|Laboratory Results||Performed at least one test of certified EHR technology’s capacity to provide electronic submissions of reportable lab results to public health agencies and follow up submission if the test Is successful (unless none of the public health agencies to which an eligible hospital or CAH submits such information has the capacity to receive the information electronically), except where prohibited.||Successful ongoing submission of electronic reportable laboratory results from CEHRT to a public health agency for the entire EHR reporting period (unless no PH agency is capable)|
The following tables detail the Public Health Stage 2 Laboratory Reporting of Reportable Diseases Objective:
|Laboratory Reporting of Reportable Disease Measure and Exclusions for Eligible Hospitals (EHs) and CAHs|
|Objective||Capability to submit electronic reportable laboratory results to public health agencies, except where prohibited, and in accordance with applicable law and practice.|
|Core Measure||Successful ongoing submission of electronic reportable laboratory results from certified EHR technology (CHERT) to a public health agency for the entire EHR reporting period.|
Any Eligible Hospital (EH) or Critical Access Hospital (CAH) that meets one or more of the following criteria:
|Reportable Laboratory Result Stage 2 Standard Requirements|
|Stage 2 Public Health MU Objectives||Stage 2 MU Exchange Standard||Stage 2 MU Vocabulary Standard|
|Electronic Lab Results (ELR) – Electronic transmission of lab results to public health agencies.||
For Providers Resending Second Stage 1 Meaningful Use Test Message for Failure.
The Oklahoma State Department of Health (OSDH) is encouraging all providers who have submitted a Meaningful Use (MU) Stage 1 test immunization or reportable disease laboratory result messages failing OSDH message validation to make the necessary system modifications and resubmit. With successful MU Stage 1 test message validation and secure messages transport capabilities, Oklahoma providers will be better prepared to meet attestation requirements for MU Stage 2.
If system modifications are not possible following a failed Stage 1 test message submission, the OSDH understands, for the purpose of meeting MU Stage 1 attestation requirements, a second message failure will occur. In the event that a provider has submitted one failed test message, makes no modifications to their system, and intends to submit a second test message for MU Stage 1 that will also fail, there is no need to submit the second test message to OSDH for validation.
Should you have any questions regarding attestation requirements for the EHR Incentive Program, please contact the appropriate agency below:
Medicare: contact information for CMS Region VI can be found at: http://www.cms.gov/RegionalOffices/Downloads/DallasRegionalOffice.pdf.
For specific information about submitting Immunization or Laboratory Result messages, CMS offers Frequently Asked Questions.